Lv4
603 积分 2021-08-19 加入
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616
1个月前
已完结
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia
1个月前
已完结
Lipoprotein(a) reduction with inclisiran, alirocumab, evolocumab, enlicitide, and lerodalcibep: A systematic review and meta-analysis of randomized controlled trials
1个月前
已完结
Oral PCSK9 inhibitor enlicitide lowers LDL cholesterol levels in phase 2 trial
1个月前
已完结
Trial of the Oral PCSK9 Inhibitor Enlicitide
1个月前
已完结
Oral PCSK9 Inhibitor Enlicitide versus Oral Non-statin Therapies: A Phase 3 Randomized Clinical Trial
1个月前
已完结
The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia
1个月前
已完结
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
1个月前
已完结
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering
1个月前
已完结
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering
1个月前
已完结
皖公网安备34019202002308
